Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)

Turkey flag Turkey · Delayed Price · Currency is TRY
92.45
+1.05 (1.15%)
Last updated: Mar 28, 2025
-50.77%
Market Cap 2.22B
Revenue (ttm) 374.49M
Net Income (ttm) -59.17M
Shares Out 23.85M
EPS (ttm) -2.48
PE Ratio n/a
Forward PE n/a
Dividend 0.41 (0.45%)
Ex-Dividend Date n/a
Volume 215,446
Average Volume 408,684
Open 92.00
Previous Close 91.40
Day's Range 89.00 - 92.50
52-Week Range 85.30 - 215.00
Beta 0.88
RSI 46.08
Earnings Date Apr 9, 2025

About IST:ONCSM

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi provides consumables, medical devices, diagnostic products, and protective equipment. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 292
Stock Exchange Istanbul Stock Exchange
Ticker Symbol ONCSM
Full Company Profile

Financial Performance

In 2024, IST:ONCSM's revenue was 374.49 million, an increase of 7.85% compared to the previous year's 347.24 million. Losses were -59.17 million, -48.65% less than in 2023.

Financial Statements

News

There is no news available yet.